| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/28/2006 | US20060216794 Hyaluronan synthase gene and uses thereof |
| 09/28/2006 | US20060216793 Culturing Bacillus strain with purified nucleic acid segment having coding region encoding enzymatically active hyaluronan synthase to produce hyaluronic acid; genetic engineering |
| 09/28/2006 | US20060216789 Method for the production of bacterial toxins |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216787 Modified Shine-Dalgarno sequences and methods of uses thereof |
| 09/28/2006 | US20060216786 Feline interferon-alpha proteins |
| 09/28/2006 | US20060216785 Genetic engineering; fusion protein; comprising a recombinant vector containing a nucleic acid sequence encoding a ubiquitin like molecule (UBL) molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell |
| 09/28/2006 | US20060216784 Process for production of polypeptides |
| 09/28/2006 | US20060216783 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/28/2006 | US20060216782 Methods for expression and purification of immunotoxins |
| 09/28/2006 | US20060216777 Immobilization on solid support |
| 09/28/2006 | US20060216772 Interfacial biomaterials for binding metal substrates |
| 09/28/2006 | US20060216764 Diagnosing prostate cancer in humans; obtaining tissue sample, monitoring marker gene expression, evaluating pattern for cancer; diagnostic and prognostic assays include methods involving the antibody-based detection of Pin1 and the amplification of Pin1 RNA |
| 09/28/2006 | US20060216758 Antibodies to transferrin receptor-like proteins |
| 09/28/2006 | US20060216755 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 09/28/2006 | US20060216750 New lipid binding protein 1 |
| 09/28/2006 | US20060216746 Novel protein and DNA thereof |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216740 Methods for the electronic, homogeneous assembly and fabrication of devices |
| 09/28/2006 | US20060216739 Insulin-like growth factor binding protein |
| 09/28/2006 | US20060216738 SNPs in 5' regulatory region of MDR1 gene |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216712 Hybridization, immobilization; genotypes |
| 09/28/2006 | US20060216710 Screening for compound that activates or inhibits activity of Aster Associated Protein; over-expression disrupts mitotic spindle assembly and leads to aberrant and abortive mitosis |
| 09/28/2006 | US20060216705 Transcription activation complex and utilization thereof |
| 09/28/2006 | US20060216703 Extraction and concentration method |
| 09/28/2006 | US20060216699 Peptides for the detection of HIV-1 group O |
| 09/28/2006 | US20060216698 Fusion expression vector containing the His-tagged Vitreoscilla hemoglobin coding gene |
| 09/28/2006 | US20060216693 Method of screening compounds which inhibit the initiation of the retrotranscription of the rna of virus hiv-1 and means for implementing same |
| 09/28/2006 | US20060216692 Switchable nucleic acids for diagnostics, screening and molecular electronics |
| 09/28/2006 | US20060216402 Starch |
| 09/28/2006 | US20060216343 Pharmaceutical compositions comprising an oligonucleotide as an active agent |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216312 Mutants of replication competent vaccinia virus |
| 09/28/2006 | US20060216311 Method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral DNA |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 09/28/2006 | US20060216307 Vaccine composition |
| 09/28/2006 | US20060216306 Epitopes of human immunodeficiency virus-1 |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216301 Kdr peptides and vaccines containing the same |
| 09/28/2006 | US20060216300 Recombinant antibodies and compositions and methods for making and using the same |
| 09/28/2006 | US20060216292 Treatment of neurodegenerative diseases |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216271 Synergistic combination of two adenoviral vectors that are replication incompetent cotranscomplements of each other and one is recombinant 1014; enhances both gene delivery and gene expression of genetic sequences contained within the vector. |
| 09/28/2006 | US20060216270 DNA 19355 polypeptide, a tumor necrosis factor homolog |
| 09/28/2006 | DE102005013779A1 Verfahren zur Herstellung von mehrfach ungesättigten C20- und C22-Fettsäuren mit mindestens vier Doppelbindungen in transgenen Pflanzen Process for the preparation of polyunsaturated C20- and C22-fatty acids with at least four double bonds in transgenic plants |
| 09/28/2006 | DE102005013676A1 Allele des zwf-Gens aus coryneformen Bakterien Alleles of the zwf gene from coryneform bacteria |
| 09/28/2006 | DE10020704B4 Biochip zur Archivierung und labormedizinischen Analyse von biologischem Probenmaterial, Verfahren zu dessen Herstellung sowie dessen Verwendung in diagnostischen Verfahren Biochip for archiving medical and laboratory analysis of biological sample material, process for its preparation and its use in diagnostic methods |
| 09/28/2006 | CA2800359A1 Chemically inducible expression of biosynthetic pathways |
| 09/28/2006 | CA2611859A1 Cellulases, nucleic acids encoding them and methods for making and using them |
| 09/28/2006 | CA2604507A1 Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same |
| 09/28/2006 | CA2603140A1 Use of bacillus licheniformis polypeptides in animal feed |
| 09/28/2006 | CA2602947A1 Method for protein purification comprising heat incubation in acetic acidic solution |
| 09/28/2006 | CA2602946A1 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 09/28/2006 | CA2602768A1 Plants having increased yield and a method for making the same |
| 09/28/2006 | CA2602676A1 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | CA2602345A1 Alteration of plant embryo/endosperm size during seed development |
| 09/28/2006 | CA2602338A1 A root-preferred, nematode-inducible soybean promoter and its use |
| 09/28/2006 | CA2602329A1 Expression of soluble, active eukaryotic glycosyltransferases in prokaryotic organisms |
| 09/28/2006 | CA2602183A1 Production of carotenoids in oleaginous yeast and fungi |
| 09/28/2006 | CA2602182A1 Influenza therapeutic |
| 09/28/2006 | CA2602143A1 Fermentation process for the production of diphtheria toxin |
| 09/28/2006 | CA2602028A1 Method for isolation of soluble polypeptides |
| 09/28/2006 | CA2601858A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | CA2601855A1 Inhibitor of peroxisome proliferator-activated receptor alpha coactivator 1 |
| 09/28/2006 | CA2601605A1 Methods for selecting drought resistant plants |
| 09/28/2006 | CA2601574A1 Methods and compositions for producing active vitamin k-dependent proteins |
| 09/28/2006 | CA2601267A1 Novel anti-plgf antibody |
| 09/28/2006 | CA2600949A1 Theileria parva dna vaccines |
| 09/28/2006 | CA2600882A1 Chemically inducible expression of biosynthetic pathways |
| 09/28/2006 | CA2600536A1 Cis-acting regulatory elements from tripsacum dactyloides |
| 09/28/2006 | CA2600286A1 Method for producing polyunsaturated c20 and c22 fatty acids with at least four double bonds in transgenic plants |
| 09/28/2006 | CA2598134A1 Ultra low strength electric field network-mediated ex vivo gene, protein and drug delivery in cells |
| 09/27/2006 | EP1705255A2 Diagnostic method and kit for determining Kell blood group genotype |
| 09/27/2006 | EP1705253A2 Compositons and methods for reverse transcriptase-Polymerase chain reaction (RT-PCR) |
| 09/27/2006 | EP1705251A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF a1,6-FUCOSYLTRANSFERASE |
| 09/27/2006 | EP1705249A1 Method for producing plants with increased biomass |
| 09/27/2006 | EP1705248A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 09/27/2006 | EP1705247A1 Dna participating in hydroxylation of macrolide compound |
| 09/27/2006 | EP1705191A2 Anti-interleukin-18 antibody |
| 09/27/2006 | EP1705189A1 Feline hepatocyte growth factor |
| 09/27/2006 | EP1705186A1 Vaccine and antibody against Dictyocaulus viviparus |
| 09/27/2006 | EP1705185A2 Reagent for the diagnosis of rheumatoid arthritis |
| 09/27/2006 | EP1705184A1 Treatment of neoplastic diseases using a combination of plasminogen activators and sulfhydryl donors |
| 09/27/2006 | EP1704922A2 System and methods for monitoring PCR processes |
| 09/27/2006 | EP1704869A1 VR-2332 viral nucleotide sequence and methods of use |
| 09/27/2006 | EP1704778A1 FO66 transgenic mice that express pathogenic mutants of the sca2 gene |
| 09/27/2006 | EP1704256A2 Detection and quantification of analytes in solution using polymers |
| 09/27/2006 | EP1704250A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 09/27/2006 | EP1704243A2 Oligonucleotide compound and method for treating nidovirus infections |
| 09/27/2006 | EP1704242A2 COMPOSITIONS OF ORTHOGONAL LEUCYL-tRNA AND AMINOACYL-tRNA SYNTHETASE PAIRS AND USES THEREOF |
| 09/27/2006 | EP1704241A2 Methods for the preparation of a fine chemical by fermentation |
| 09/27/2006 | EP1704239A1 Integrase fusion proteins and their use with integrating gene therapy |
| 09/27/2006 | EP1704238A1 Cattle beta-casein gene targeting vector using homologous recombination |
| 09/27/2006 | EP1704237A1 Ccamk involved in nodulation and endomycorrhization |
| 09/27/2006 | EP1704236A1 Proteins |
| 09/27/2006 | EP1704235A2 The mycolactone locus : an assembly line for producing novel polyketides, with therapeutic and prophylatic uses |
| 09/27/2006 | EP1704234A2 Production of glucagon like peptide 2 and analogs |
| 09/27/2006 | EP1704233A2 New plasmids, their derivatives and fragments, their methods of manufacture and application |